Trade Summary

2 days ago, Sweeny Nicole, serving as Chief Commercial Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 1,489 shares at $26.78 per share, for a total transaction value of $39,872.14. Following this transaction, Sweeny Nicole now holds 59,291 shares of KALV.

This sale represents a 2.45% decrease in Sweeny Nicole's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 4:05 PM ET, 1 day after the trade was made.

KalVista Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.